ProCE Banner Activity

CE / CME

Expert Insights: Addressing the Physical and Emotional Challenges of Children and Adolescents With Psoriasis

In this engaging, interactive video roundtable, expert faculty review the clinical presentation of psoriasis in infants, children, and adolescents, and discuss strategies to address psychosocial elements of the disease in these patients. Additional discussion covers novel and emerging therapies as well as screening for common comorbidities, including juvenile psoriatic arthritis.

Registered Nurses AANP : 0.75 AANP contact {hour}

Physicians: Maximum of 0.75 AMA PRA Category 1 Credit

Released: February 07, 2022

Expiration: February 06, 2023

No longer available for credit.

Share

Faculty

Victoria Garcia-Albea

Victoria Garcia-Albea, PNP, DCNP

Director, Lahey Dermatology Nurse Practitioner Training Program
Lahey Dermatology
Burlington, Massachusetts

Robert Sidbury

Robert Sidbury, MD, MPH

Professor, Department of Pediatrics
Chief, Division of Dermatology
Seattle Childrens Hospital
University of Washington School of Medicine
Seattle, Washington

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Novartis Pharmaceuticals Corporation

Target Audience

This program is intended for dermatology, rheumatology and pediatric physicians, nurse practitioners, nurses and other healthcare professionals who manage patients with psoriatic disease.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Summarize differences in the clinical presentation of psoriasis in infants, children, and adolescents
  • Explore strategies to address psychosocial and quality of life concerns in pediatric patients with psoriasis
  • Identify the appropriate use of novel and emerging therapies for psoriasis in pediatric patients
  • Apply appropriate strategies for screening for juvenile psoriatic arthritis and other comorbidities in pediatric patients with psoriasis

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure

Primary Author

Victoria Garcia-Albea, PNP, DCNP

Director, Lahey Dermatology Nurse Practitioner Training Program
Lahey Dermatology
Burlington, Massachusetts

Victoria Garcia-Albea, NP, DCNP, has disclosed that she has received consulting fees from Sanofi Genzyme.

Robert Sidbury, MD, MPH

Professor, Department of Pediatrics
Chief, Division of Dermatology
Seattle Childrens Hospital
University of Washington School of Medicine
Seattle, Washington

Robert Sidbury MD, MPH, has disclosed that he has received funds for research support from Galderma, Micreos, Regeneron, and UCB.

Staff Disclosure

Staff

Craig Borders,

Vice President, Managing Scientific Director

Craig Borders has no relevant conflicts of interest to report.

Ruth Cohen,

Ruth Cohen Cooper, CHCP, has no relevant conflicts of interest to report.

Kiran Mir-Hudgeons, PhD

Clinical Editor

Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.

Instructions for Credit

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement

This program is accredited for 0.75 NAPNAP CE contact hour of which 0.25 contain pharmacology content, per the National Association of Pediatric Nurse Practitioners Continuing Education Guidelines.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Additional Information

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from February 07, 2022, through February 06, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve disease outcomes, quality of life, and psychosocial development in children and adolescents with psoriasis by improving the knowledge and competence of healthcare professionals providing psoriasis care for pediatric patients.